BVF PARTNERS L P/IL Insider Trading $ALPN ALPINE IMMUNE SCIENCES, INC.
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).
BVF PARTNERS L P/IL in ALPINE IMMUNE SCIENCES, INC.
Trading Symbol: ALPNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 1,109,258 shares
Current Value: $2,595,664
Latest Transaction: Jun 22 2017
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in ALPINE IMMUNE SCIENCES, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 1,715 | 3,859 | 201,811 | 200.1 K to 201.8 K (+0.86 %) |
Jun 22 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 6,359 | 14,308 | 717,089 | 710.7 K to 717.1 K (+0.89 %) |
Jun 22 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 9,732 | 21,897 | 1,109,258 | 1.1 M to 1.1 M (+0.89 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.28 | 3,673 | 8,379 | 200,096 | 196.4 K to 200.1 K (+1.87 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.28 | 13,046 | 29,762 | 710,730 | 697.7 K to 710.7 K (+1.87 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.28 | 20,181 | 46,039 | 1,099,526 | 1.1 M to 1.1 M (+1.87 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.29 | 3,920 | 8,979 | 196,423 | 192.5 K to 196.4 K (+2.04 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.29 | 12,624 | 28,917 | 697,684 | 685.1 K to 697.7 K (+1.84 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.29 | 19,206 | 43,993 | 1,079,345 | 1.1 M to 1.1 M (+1.81 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 2,727 | 6,128 | 192,503 | 189.8 K to 192.5 K (+1.44 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 10,023 | 22,522 | 685,060 | 675 K to 685.1 K (+1.48 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 15,350 | 34,491 | 1,060,139 | 1 M to 1.1 M (+1.47 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 1,805 | 4,144 | 189,776 | 188 K to 189.8 K (+0.96 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 6,903 | 15,847 | 675,037 | 668.1 K to 675 K (+1.03 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 10,192 | 23,398 | 1,044,789 | 1 M to 1 M (+0.99 %) |
May 19 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 1,124 | 2,585 | 187,971 | 186.8 K to 188 K (+0.60 %) |
May 19 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 4,223 | 9,713 | 668,134 | 663.9 K to 668.1 K (+0.64 %) |
May 19 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 6,253 | 14,382 | 1,034,597 | 1 M to 1 M (+0.61 %) |
May 19 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 2,909 | 6,690 | 186,847 | 183.9 K to 186.8 K (+1.58 %) |
May 19 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 10,541 | 24,242 | 663,911 | 653.4 K to 663.9 K (+1.61 %) |
May 19 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 16,436 | 37,800 | 1,028,344 | 1 M to 1 M (+1.62 %) |
May 19 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 5,510 | 12,666 | 183,938 | 178.4 K to 183.9 K (+3.09 %) |
May 19 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 6,897 | 15,854 | 653,370 | 646.5 K to 653.4 K (+1.07 %) |
May 19 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 24,965 | 57,387 | 1,011,908 | 986.9 K to 1 M (+2.53 %) |
May 11 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.34 | 675 | 1,581 | 178,428 | 177.8 K to 178.4 K (+0.38 %) |
May 11 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.34 | 2,565 | 6,010 | 646,473 | 643.9 K to 646.5 K (+0.40 %) |
May 11 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.34 | 3,794 | 8,889 | 986,943 | 983.1 K to 986.9 K (+0.39 %) |
May 11 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.35 | 6,217 | 14,583 | 177,753 | 171.5 K to 177.8 K (+3.62 %) |
May 11 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.35 | 22,092 | 51,821 | 643,908 | 621.8 K to 643.9 K (+3.55 %) |
May 11 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.35 | 33,691 | 79,029 | 983,149 | 949.5 K to 983.1 K (+3.55 %) |
May 11 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.29 | 3,929 | 8,989 | 171,536 | 167.6 K to 171.5 K (+2.34 %) |
May 11 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.29 | 14,274 | 32,657 | 621,816 | 607.5 K to 621.8 K (+2.35 %) |
May 11 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.29 | 21,797 | 49,869 | 949,458 | 927.7 K to 949.5 K (+2.35 %) |
Page: 1